These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8296378)

  • 1. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma).
    Myat-Phone-Kyaw ; Myint-Oo ; Myint-Lwin ; Thaw-Zin ; Kyin-Hla-Aye ; Nwe-Nwe-Yin
    Trans R Soc Trop Med Hyg; 1993; 87(6):687. PubMed ID: 8296378
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of resistance to chloroquine by Plasmodium vivax in Myanmar.
    Marlar-Than ; Myat-Phone-Kyaw ; Aye-Yu-Soe ; Khaing-Khaing-Gyi ; Ma-Sabai ; Myint-Oo
    Trans R Soc Trop Med Hyg; 1995; 89(3):307-8. PubMed ID: 7660445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.
    Tasanor O; Ruengweerayut R; Sirichaisinthop J; Congpuong K; Wernsdorfer WH; Na-Bangchang K
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):410-8. PubMed ID: 16497347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine resistance in Plasmodium vivax.
    Baird JK
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4075-83. PubMed ID: 15504824
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital malaria due to chloroquine-resistant Plasmodium vivax: a case report.
    Mohan K; Maithani MM
    J Trop Pediatr; 2010 Dec; 56(6):454-5. PubMed ID: 20388657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009-2016).
    Nyunt MH; Han JH; Wang B; Aye KM; Aye KH; Lee SK; Htut Y; Kyaw MP; Han KT; Han ET
    Malar J; 2017 Mar; 16(1):117. PubMed ID: 28298235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malaria.
    Uppal K; Salinas JL; Monteiro WM; Val F; Cordy RJ; Liu K; Melo GC; Siqueira AM; Magalhaes B; Galinski MR; Lacerda MVG; Jones DP
    PLoS One; 2017; 12(8):e0182819. PubMed ID: 28813452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on Plasmodium vivax chloroquine resistance].
    Li JY; Li Q; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):326-31. PubMed ID: 25345166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
    Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primaquine-resistant Plasmodium vivax malaria.
    Luzzi GA; Warrell DA; Barnes AJ; Dunbar EM
    Lancet; 1992 Aug; 340(8814):310. PubMed ID: 1353224
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
    Guthmann JP; Pittet A; Lesage A; Imwong M; Lindegardh N; Min Lwin M; Zaw T; Annerberg A; de Radiguès X; Nosten F
    Trop Med Int Health; 2008 Jan; 13(1):91-8. PubMed ID: 18291007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine-resistant Plasmodium vivax in Brazil.
    Bada JL; Cabezos J
    Trans R Soc Trop Med Hyg; 1992; 86(5):570; author reply 571. PubMed ID: 1475838
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine-resistant Plasmodium vivax in Brazil.
    Loyola EG; Rodriguez MH
    Trans R Soc Trop Med Hyg; 1992; 86(5):570; author reply 571. PubMed ID: 1475839
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine-resistant Plasmodium vivax in Brazil.
    Canessa A; Mazzarello G; Cruciani M; Bassetti D
    Trans R Soc Trop Med Hyg; 1992; 86(5):570-1. PubMed ID: 1475840
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.
    Garg S; Saxena V; Lumb V; Pakalapati D; Boopathi PA; Subudhi AK; Chowdhury S; Kochar SK; Kochar DK; Sharma YD; Das A
    Exp Parasitol; 2012 Dec; 132(4):410-6. PubMed ID: 23043980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine-resistant Plasmodium vivax from Lombok.
    McCullough TJ; Rajabalendaran N; Kirubakaran M; Mollison LC
    Med J Aust; 1993 Aug; 159(3):211. PubMed ID: 8380027
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India.
    Nandy A; Addy M; Maji AK; Bandyopadhyay AK
    Ann Trop Med Parasitol; 2003 Apr; 97(3):215-20. PubMed ID: 12803853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine-resistant Plasmodium vivax: how common?
    Hanna J
    Med J Aust; 1993 Apr; 158(7):502-3. PubMed ID: 8469207
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative characterization of hemozoin in Plasmodium berghei and vivax.
    Pisciotta JM; Scholl PF; Shuman JL; Shualev V; Sullivan DJ
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):110-119. PubMed ID: 28279945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.